Tomiko Sunaga, Masayuki Maeda, Rosella Saulle, Sueko M Ng, Miki Takenaka Sato, Takeshi Hasegawa, Andrew N Mason, Hisashi Noma, Erika Ota. Anti-vascular endothelial growth factor biosimilars for neovascular age-related macular degeneration. The Cochrane database of systematic reviews. 2024. 6. 6. CD015804
Masayuki Maeda, Tomiko Sunaga, Miki Takenaka Sato, Takeshi Hasegawa, Hisashi Noma, Erika Ota. Efficacy of carbapenems and alternative antimicrobials for treating complicated urinary tract infections caused by third-generation cephalosporin-resistant gram-negative bacteria: A systematic review and meta-analysis of randomised controlled trials. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2024
Kozue Yamaguchi, Masayuki Maeda, Norio Ohmagari, Yuichi Muraki. Relationship between carbapenem use and major diagnostic category in curative care beds: Analysis of a 2020 Japanese national administrative database. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2023
Tomiko Sunaga, Masayuki Maeda, Takeshi Hasegawa, Andrew N. Mason, Hisashi Noma, Erika Ota. Anti-vascular endothelial growth factor biosimilars for macular degeneration. Cochrane Database of Systematic Reviews. 2023. 2023. 8
The current situation of antimicrobial stewardship programs and health policy in Japan
(14th International Symposium on Antimicrobial Agents and Resistance (ISAAR) & 2024 Annual Conference of the Korean Society of Antimicrobial Therapy (KSAT) 2024)
Evidence-based health policy making and board certification system for infection control pharmacy specialists in Japan
(2022 Forbidden City International Pharmacist Conference 2022)